Effects of Ligustrum delavayanum Hariot. on cholesterol levels and arrhythmogenesis induced by myocardial ischaemia-reperfusion injury in diabetic-hypercholesterolaemic rats

Environmental Toxicology and Pharmacology

Volumn 26, Issue 2, 2008, Pages 255-258

  Adameová, Adriana ^a   Mučaji, Pavol ^a   Švec, Pavel ^a   Nagy, Milan ^a   Faberová, Viera ^b   Kuželová, Magdaléna ^a  

^a Faculty of Natural Sciences   (Slovakia)

^b VULM as   (Slovakia)

Author keywords

Experimental acute diabetes and hypercholesterolaemia; Ligustrum delavayanum; Myocardial ischaemia reperfusion injury; Rats

Indexed keywords

CHOLESTEROL; GLUCOSE; LIGUSTRUM DELAVAYANUM EXTRACT; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARRHYTHMOGENESIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; GLUCOSE BLOOD LEVEL; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FIBRILLATION; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; LIGUSTRUM; LIGUSTRUM DELAVAYANUM; MALE; NONHUMAN; PLANT LEAF; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SINGLE DRUG DOSE; TACHYCARDIA;

LIGUSTRUM; LIGUSTRUM DELAVAYANUM; OLEACEAE; RATTUS;

EID: 47849084466     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etap.2008.03.012     Document Type: Article

References (30)

1. Adameová A., Kuželová M., Andelová E., Faberová V., Pancza D., Švec P., Ziegelhoffer A., and Ravingerová T. Hypercholesterolemia abrogates an increased resistance of diabetic rat hearts to ischemia-reperfusion injury. Mol. Cell Biochem. 295 (2007) 129-136
2. Adameová A., Ravingerová T., Faberová V., Švec P., and Kuželová M. The myocardial infarct size-limiting and antiarrhythmic effects of acyl-CoA:cholesterol acyltransferase inhibitor VULM 1457 protect the hearts of diabetic-hypercholesterolaemic rats against ischaemia/reperfusion injury both in vitro and in vivo. Eur. J. Pharmacol. 576 (2007) 114-121
3. Baroniková S., Nagy M., and Grančai D. Changes in immunomodulatory activity of human mononuclear cells after cultivation with leaf decoctions from the genus Ligustrum L. Phytother. Res. 13 (1999) 692-695
4. Bays H., and Stein E.A. Pharmacotherapy for dyslipidaemia-current therapies and future agents. Expert. Opin. Pharmacother. 4 (2003) 1901-1938
5. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37 (1959) 911-917
6. Brown H.R., Zlatkis A., and Zak B. Rapid procedure for determination of free serum cholesterol. Anal. Chem. 26 (1954) 397-399
7. Elsasser A., Suzuki K., Lorenz-Meyer S., Bode C., and Schaper J. The role of apoptosis in myocardial ischaemia: a critical appraisal. Basic Res. Cardiol. 96 (2001) 219-226
8. Frisinghelli A., and Mafrici A. Regression or reduction in progression of atherosclerosis, and avoidance of coronary events, with lovastatin in patients with or at high risk of cardiovascular disease. Clin. Drug Invest. 27 (2007) 591-604
9. Fukuda T., Kitada Y., Chen X.M., Yang L., and Miyase T. Two new monoterpene glycosides from ku-ding-cha. Inhibitors of acyl-CoA: cholesterol acyltransferase (ACAT). Chem. Pharm. Bull. 44 (1996) 2173-2176
10. Hammermann A.F., Damirov J.A., and Sokolov W.S. Einige Aussichtsreiche Pflanzen der Volksmedizin von Azerbajdschan. Planta Med. 20 (1971) 374-380
11. Ikenoya M., Yoshinaka Y., Kobayashi H., Kawamine K., Shibuya K., Sato F., Sawanobori K., Watanabe T., and Miyazaki A. A selective ACAT-1 inhibitor, K-604, suppresses fatty streak lesions in fat-fed hamsters without affecting plasma cholesterol levels. Atherosclerosis 191 (2007) 290-297
12. Keech A., Simes R.J., Barter P., Best J., Scott R., Taskinen M.R., Forder P., Pillai A., Davis T., Glasziou P., Drury P., Kesaniemi Y.A., Sullivan D., Hunt D., Colman P., d'Emden M., Whiting M., Ehnholm C., and Laakso M. FIELD study investigators. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 366 (2005) 1849-1861
13. Kiss A.K., Derwinska M., and Melzig M.F. Dual inhibition of metallopeptidases (ACE and NEP) by iridoids from Ligustrum vulgare L. leaf. Planta Med. 73 (2007) 972
14. Lau K.M., He Z.D., Dong H., Fung K.P., and But P.P. Anti-oxidative, anti-inflammatory and hepato-protective effects of Ligustrum robustum. J. Ethnopharmacol. 83 (2002) 63-71
15. Lefer D.J., Scalia R., Jones S.T., Sharo B.R., Hoffmeyer M.R., Farvid A.R., Gibson M.F., and Lefer A.M. HMG-CoA reductase inhibition protects the diabetic myocardium from ischemia-reperfusion injury. FASEB J. 15 (2001) 1454-1456
16. Lin H.M., Yen F.L., Ng L.T., and Lin C.C. Protective effects of Ligustrum lucidum fruit extract on acute butylated hydroxytoluene-induced oxidative stress in rats. J. Ethnopharmacol. 111 (2007) 129-136
17. Ludwig S., and Shen G.X. Statins for diabetic cardiovascular complications. Curr. Vasc. Pharmacol. 4 (2006) 245-251
18. Ma S.C., He Z.D., Deng X.L., But P.P., Ooi V.E., Xu H.X., Lee S.H., and Lee S.F. In vitro evaluation of secoiridoid glucosides from the fruits of Ligustrum lucidum as antiviral agents. Chem. Pharm. Bull. 49 (2001) 1471-1473
19. Moens A.L., Claeys M.J., Timmermans J.P., and Vrints C.J. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int. J. Cardiol. 20 (2005) 179-190
20. Nagy M., Spilková J., Vrchovská V., Šeršeň F., Mučaji P., Grančai D., and Kontšeková Z. Free radical scavenging activity of different extracts and some constituents from the leaves of Ligustrum vulgare and L. delavayanum. Fitoterapia 77 (2006) 395-397
21. Nakamura S., Kamiya S., Shirahase H., Kanda M., Yoshimi A., Tarumi T., and Kurahashi K. Hypolipidemic and antioxidant activity of the novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor KY-455 in rabbits and hamsters. Arzneimittelforschung 54 (2004) 102-108
22. Ouyang M.A., He Z.D., and Wu C.L. Anti-oxidative activity of glycosides from Ligustrum sinense. Nat. Prod. Res. 17 (2003) 381-387
23. PhBs IV, 1987. Pharmacopoea Bohemoslovaca, 4th edition. Avicenum, Praha, pp. 43-45.
24. Scalia R., Gooszen M.E., Jones S.P., Hoffmeyer M., Rimmer III D.M., Trocha S.D., Huang P.L., Smith M.B., Lefer A.M., and Lefer D.J. Simvastatin exerts both anti-inflammatory and cardioprotective effects in apolipoprotein E-deficient mice. Circulation 103 (2001) 2598-2603
25. Shoemaker M., Hamilton B., Dairkee S.H., Cohen I., and Campbell M.J. In vitro anticancer activity of twelve Chinese medicinal herbs. Phytother. Res. 19 (2005) 649-651
26. Stankovičová T., Frýdl M., Kubicová M., Baróniková S., Nagy M., Grančai D., and Švec P. The effect of Ligustrum delavayanum on isolated perfused rat heart. Exp. Clin. Cardiol. 6 (2001) 132-136
27. Terasaka N., Miyazaki A., Kasanuki N., Ito K., Ubukata N., Koieyama T., Kitayama K., Tanimoto T., Maeda N., and Inaba T. ACAT inhibitor pactimibe sulfate (CS-505) reduces and stabilizes atherosclerotic lesions by cholesterol-lowering and direct effects in apolipoprotein E-deficient mice. Atherosclerosis 190 (2007) 239-247
28. Walker M.J., Curtis M.J., Hearse D.J., Campbell R.W., Janse M.J., Yellon D.M., Cobbe S.M., Coker S.J., Harness J.B., Harron D.W., Higgins A.J., Julian D.G., Lab M.J., Manning A.S., Northover B.J., Parratt J.R., Riemersma R.A., Riva E., Russell D.C., Sheridan D.J., Winslow E., and Woodward B. The Lambeth conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc. Res. 22 (1988) 447-455
29. Wang S.S., Chen J.H., and Liu X.J. Preliminary study on pharmacologic action of Ligustrum japonicum. Zhongguo Zhong Xi Yi Jie He Za Zhi 14 (1994) 670-672
30. Yim T.K., Wu W.K., Pak W.F., and Ko K.M. Hepatoprotective action of an oleanolic acid-enriched extract of Ligustrum lucidum fruits is mediated through an enhancement on hepatic glutathione regeneration capacity in mice. Phytother. Res. 15 (2001) 589-592